Cancer 
        Digest        

Image representing Covid lung infection generated by Wix AI CANCER DIGEST – March 16, 2026 – Scientists have discovered that serious viral lung infections that require hospitalization can alter immune cells in the lungs, leaving behind chronic inflammation that may help tumors develop months or years later, but that vaccination heads off those harmful effects. The study led by Jie Sun, PhD at the University of Virginia Health looked at the harmful effects of severe Covid-19 a

A new large-scale analysis of older adults with advanced cancer reveals a stark "preference gap" in modern oncology, showing that clinical treatments rarely align with what patients actually value most.

Targeted therapies that have pushed significantly higher survival rates for colorectal cancer, gastric cancer, liver cancer, and gastrointestinal stromal tumors, may have unrecognized long-term toxic side effects, according to an international group of researchers.

After two years, patients receiving gemcitabine and Elenagen survived twice as long as those treated with chemotherapy alone.

Most American women prefer to have their cervical cancer screening done by a professional in a doctor’s office despite the availability of newly FDA-approved at-home screening kits.

Metastatic melanoma cells – Image Credit National Cancer Institute CANCER DIGEST – Jan. 24, 2026 – When a personalized mRNA cancer vaccine is added to an immunotherapy for the treatment of advanced melanoma, more patients survived without recurrence than those treated with pembrolizumab (Keytruda®) alone, the five-year updated results of a clinical trial show. The KEYNOTE-942 ongoing clinical trial ( NCT03897881 ) compares the effectiveness of treatment of patients with stage